Medi-Tate Ltd. announced that it has received $10 million in an equity funding on March 19, 2018. The transaction will include participation from existing investor, Xenia Venture Capital Ltd. After the completion of the transaction, Xenia Venture Capital Ltd will hold 15.51% stake in the company on fully diluted basis.